Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit

Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):628-36. doi: 10.1161/ATVBAHA.114.304747. Epub 2015 Jan 29.

Abstract

Objective: High-density lipoproteins (HDLs) can potentially protect against atherosclerosis by multiple mechanisms, including enhancement of endothelial repair and improvement of endothelial function. This study asks if increasing HDL levels by inhibiting cholesteryl ester transfer protein activity with the anacetrapib analog, des-fluoro-anacetrapib, enhances endothelial repair and improves endothelial function in New Zealand White rabbits with balloon injury of the abdominal aorta.

Approach and results: New Zealand White rabbits received chow or chow supplemented with 0.07% or 0.14% (wt/wt) des-fluoro-anacetrapib for 8 weeks. Endothelial denudation of the abdominal aorta was carried out after 2 weeks. The animals were euthanized 6 weeks postinjury. Treatment with 0.07% and 0.14% des-fluoro-anacetrapib reduced cholesteryl ester transfer protein activity by 81±4.9% and 92±12%, increased plasma apolipoprotein A-I levels by 1.4±0.1-fold and 1.5±0.1-fold, increased plasma HDL-cholesterol levels by 1.8±0.2-fold and 1.9±0.1-fold, reduced intimal hyperplasia by 37±11% and 51±10%, and inhibited vascular cell proliferation by 25±6.1% and 35±6.7%, respectively. Re-endothelialization of the injured aorta increased from 43±6.7% (control) to 69±6.6% and 76±7.7% in the 0.07% and 0.14% des-fluoro-anacetrapib-treated animals, respectively. Aortic ring relaxation and guanosine 3',5'-cyclic monophosphate production in response to acetylcholine were also improved. Incubation of HDLs from the des-fluoro-anacetrapib-treated animals with human coronary artery endothelial cells increased cell proliferation and migration relative to control. These effects were abolished by knockdown of scavenger receptor-B1 and PDZ domain-containing protein 1 and by pharmacological inhibition of phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt.

Conclusions: Increasing HDL levels by inhibiting cholesteryl ester transfer protein reduces intimal thickening and regenerates functional endothelium in damaged New Zealand White rabbit aortas in an scavenger receptor-B1-dependent and phosphatidylinositol-4,5-bisphosphate 3-kinase/Akt-dependent manner.

Keywords: cholesteryl ester transfer protein; endothelium; inhibition; lipoproteins, HDL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Aorta, Abdominal / drug effects*
  • Aorta, Abdominal / injuries
  • Aorta, Abdominal / metabolism
  • Aorta, Abdominal / pathology
  • Aorta, Abdominal / physiopathology
  • Apolipoprotein A-I / blood
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Cholesterol Ester Transfer Proteins / metabolism
  • Cholesterol, HDL / blood
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / injuries
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiopathology
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Human Umbilical Vein Endothelial Cells / pathology
  • Humans
  • Hyperplasia
  • Male
  • Membrane Proteins
  • Neointima
  • Oxazolidinones / pharmacology*
  • Phosphotransferases (Alcohol Group Acceptor) / antagonists & inhibitors
  • Phosphotransferases (Alcohol Group Acceptor) / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA Interference
  • Rabbits
  • Regeneration / drug effects*
  • Scavenger Receptors, Class B / genetics
  • Scavenger Receptors, Class B / metabolism
  • Signal Transduction / drug effects
  • Time Factors
  • Transfection
  • Up-Regulation
  • Vascular System Injuries / blood
  • Vascular System Injuries / drug therapy*
  • Vascular System Injuries / pathology
  • Vascular System Injuries / physiopathology
  • Vasodilation / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Anticholesteremic Agents
  • Apolipoprotein A-I
  • Carrier Proteins
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Membrane Proteins
  • Oxazolidinones
  • PDZK1 protein, human
  • Protein Kinase Inhibitors
  • SCARB1 protein, human
  • Scavenger Receptors, Class B
  • Vasodilator Agents
  • Phosphotransferases (Alcohol Group Acceptor)
  • phosphatidylinositol 4,5-biphosphate kinase
  • Proto-Oncogene Proteins c-akt
  • anacetrapib